crescentmotor
4 minutes ago
But in the case of Blarcamisine, "sufficient" efficacy is up for debate (given the known data).
Granted, the efficacy of Blarcamesine is still under study but, with the favorable peer review, the winds look favorable. And then what else? There's the safety question where Blarcamesi